Rakovina Therapeutics Inc. (TSXV: RKV)
Health Care · Biotechnology · CA
CA$0.23
-14.81% today · -20.6% 1Y
Rakovina Therapeutics Inc. (TSXV: RKV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.45M.
Over the last twelve months the share price has lost 20.6%, trading between 0.09 and 0.37.
Tweenvest scores Rakovina Therapeutics Inc. across four factors: quality 8/100, value 55/100. Its strongest factor is value.
RKV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.45M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.32
- Dividend yield
- —
- Beta (5Y)
- -0.24
- 52-week high
- CA$0.37
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 44.59M
- Employees
- —
- Next earnings
- —
About Rakovina Therapeutics Inc.
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
- ISIN
- CA75103L3092
- Listed since
- Apr 1, 2021
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €— | — |
| Aprea Therapeutics, Inc.NasdaqCM: APRE | $8.75M | $0.56 | -19.68% |
| FibroBiologics, Inc.NasdaqCM: FBLG | $8.63M | $1.11 | -10.48% |
| Eusol Biotech Co.,Ltd.UNQ: 6652 | $8.45M | NT$— | — |
| Cizzle Biotechnology Holdings PlcLSE: CIZ | $8.43M | £0.01 | -3.33% |
| OSR Health, Inc.OTCPK: OSRH | $8.43M | $0.24 | +6.67% |
| Longeveron Inc.NasdaqCM: LGVN | $8.23M | $2.37 | -8.14% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $8.16M | ₪0.02 | +5.56% |
Figures last refreshed Oct 4, 2026.